178 related articles for article (PubMed ID: 9034938)
21. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
22. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
Howden CW; Tsai HH; Reid JL
Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of acute stomach ulcer with H2 receptor antagonists. A direct therapy comparison with 300 mg nizatidine nightly and 2 times 150 mg nizatidine with twice daily 150 mg ranitidine].
Arnold R; Beckenbach P; Bock H; Bormann R; Brunner G; Daake H; Dammann HG; Dietrich K; Fuerer M; Geiter B
Fortschr Med; 1989 Jun; 107(17):390-4. PubMed ID: 2568327
[TBL] [Abstract][Full Text] [Related]
24. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
25. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
Pace F; Colombo E; Ferrara A; Prada A; Rocca F; Bianchi Porro G
Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
[TBL] [Abstract][Full Text] [Related]
26. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
27. The effect of a single oral morning dose of nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin stimulation.
Lazzaroni M; Sangaletti O; Bianchi Porro G
J Int Med Res; 1992 Nov; 20(6):454-60. PubMed ID: 1286739
[TBL] [Abstract][Full Text] [Related]
28. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
29. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
30. Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer.
Wilder-Smith CH; Halter F; Merki HS
Dig Dis Sci; 1991 Dec; 36(12):1685-90. PubMed ID: 1748035
[TBL] [Abstract][Full Text] [Related]
31. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
33. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
34. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
Labenz J; Tillenburg B; Peitz U; Verdú E; Stolte M; Börsch G; Blum AL
Gut; 1997 Jul; 41(1):33-6. PubMed ID: 9274468
[TBL] [Abstract][Full Text] [Related]
35. Can higher doses of an H2-receptor antagonist accelerate duodenal ulcer healing?
Page MC; Lacey LA; Mills JG; Wood JR
Aliment Pharmacol Ther; 1989 Oct; 3(5):425-33. PubMed ID: 2577498
[TBL] [Abstract][Full Text] [Related]
36. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
37. Effect of nizatidine versus ranitidine on gastric intraluminal prostaglandin release in duodenal ulcer patients.
Silecchia G; Spaziani E; Guarino E; Neri T; Grasso E; Mariani P; Materia A; Genco A; Basso N
Scand J Gastroenterol Suppl; 1994; 206():8-13. PubMed ID: 7863255
[TBL] [Abstract][Full Text] [Related]
38. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
[TBL] [Abstract][Full Text] [Related]
39. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
Hurlimann S; Abbühl B; Inauen W; Halter F
Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
[TBL] [Abstract][Full Text] [Related]
40. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
Lazzaroni M; Bianchi Porro G
Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]